Denice Torres's Net Worth
$2.95 Million
Who is Denice Torres?
Denice Torres has an estimated net worth of $2.95 Million. This is based on reported shares across multiple companies, which include GLAUKOS Corp, 2seventy bio, Inc., Karuna Therapeutics, Inc., bluebird bio, Inc., and Surface Oncology, Inc..
SEC CIK
Denice Torres's CIK is 0001820278
Past Insider Trading and Trends
2021 was Denice Torres's most active year for acquiring shares with 13 total transactions. Denice Torres's most active month to acquire stocks was the month of May. 2024 was Denice Torres's most active year for disposing of shares, totalling 5 transactions. Denice Torres's most active month to dispose stocks was the month of February. 2021 saw Denice Torres paying a total of $0.00 for 67,184 shares, this is the most they've acquired in one year. In 2024 Denice Torres cashed out on 41,394 shares for a total of $8,998,054.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GLAUKOS Corp (GKOS) Snapshot price: $129.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +9.85% | 1.72K |
—
|
—
| 19.14K |
May 30
| |||
Form 4
| +5.41% | 895 |
—
|
—
| 17.43K |
Jan 2
| |||
Form 4
| +24.28% | 3.23K |
—
|
—
| 16.53K |
Jun 1
| |||
Form 4
| +13.40% | 1.57K |
—
|
—
| 13.3K |
Jan 3
| |||
Form 4
| +59.25% | 4.36K |
—
|
—
| 11.73K |
Jun 2
| |||
Form 4
| +24.62% | 1.46K |
—
|
—
| 7.37K |
Jan 3
| |||
Form 4
| +67.52% | 2.38K |
—
|
—
| 5.91K |
Jun 3
| |||
Form 4
|
∞
| 3.53K |
—
|
—
| 3.53K |
Mar 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
2seventy bio, Inc. (TSVT) Snapshot price: $4.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +61.76% | 12.05K |
—
|
—
| 31.56K |
Jun 10
| |||
Form 4
| +75.61% | 8.4K |
—
|
—
| 19.51K |
Jun 13
| |||
Form 4
| +281.79% | 8.2K |
—
|
—
| 11.11K |
Jun 8
| |||
Form 4
| +274.67% | 2.49K |
—
|
—
| 3.4K |
Nov 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Karuna Therapeutics, Inc. (KRTX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -990.00 |
$330.00 | -$326,700.00 |
0
|
Mar 18
| |||
Form 4
|
∞
| 990 |
—
|
—
| 990 |
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
bluebird bio, Inc. (BLUE) Snapshot price: $0.53
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +118.08% | 1.48K |
—
|
—
| 2.73K |
Nov 11
| |||
Form 4
| +113.05% | 3.11K |
—
|
—
| 5.86K |
Jun 15
| |||
Form 4
| +450.00% | 2.25K |
—
|
—
| 2.75K |
Aug 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Surface Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||